497
Participants
Start Date
April 30, 2004
Study Completion Date
October 31, 2004
Ciprofloxacin single dose
Patients randomized to this regimen will receive a single-dose of ciprofloxacin MR 1000 mg PO approximately 2 to 3 hours prior to the TRNBP. Patients will also receive two doses of matching placebo approximately 24 hours prior to and approximately 24 hours after the TRNBP.
Ciprofloxacin triple dose
Patients randomized to this regimen will receive three doses of ciprofloxacin MR 1000 mg PO. The doses will be approximately 24 hours prior to the TRNBP, approximately 2 to 3 hours prior to the TRNBP, and approximately 24 hours after the TRNBP.
Philadelphia
Milan
Norfolk
Bergamo
Madrid
Simpsonville
Roswell
Atlanta
Ocala
Padua
Birmingham
Vigo
Seville
Zapopan
Valencia
Chicago
Monterrey
San Antonio
Napoli
Villahermosa
Sherman Oaks
San Diego
San Francisco
Spokane
Waterbury
Hopedale
New Brunswick
Cincinnati
Columbus
Salvador
Belo Horizonte
Rio de Janeiro
Porto Alegre
São Paulo
Calgary
Edmonton
Victoria
Hamilton
Kingston
London
Toronto
Toronto
Chicoutimi
Fleurimont
Laval
Québec
Roma
México D.F.
México, D. F.
México, D.F.
Barcelona
Lead Sponsor
Bayer
INDUSTRY